Abstract:Intrinsically disordered proteins (IDPs) engage in various fundamental biological activities, and their behavior is of particular importance for a better understanding of the verbose but well-organized signal transduction in cells. IDPs exhibit uniquely paradoxical features with low affinity but simultaneously high specificity in recognizing their binding targets. The transcription factor p53 plays a crucial role in cancer suppression, carrying out some of its biological functions using its disordered regions, such as N-terminal transactivation domain 2 (TAD2). Exploration of the binding and unbinding processes between proteins is challenging, and the inherently disordered properties of these regions further complicate the issue. Computer simulations are a powerful tool to complement the experiments to fill gaps to explore the binding/unbinding processes between proteins. Here, we investigated the binding mechanism between p300 Taz2 and p53 TAD2 through extensive molecular dynamics (MD) simulations using the physics-based UNited RESidue (UNRES) force field with additional Go̅-like potentials. Distance restraints extracted from the NMR-resolved structures were imposed on intermolecular residue pairs to accelerate binding simulations, in which Taz2 was immobilized in a native-like conformation and disordered TAD2 was fully free. Starting from six structures with TAD2 placed at different positions around Taz2, we observed a metastable intermediate state in which the middle helical segment of TAD2 is anchored in the binding pocket, highlighting the significance of the TAD2 helix in directing protein recognition. Physics-based binding simulations show that successful binding is achieved after a series of stages, including (1) protein collisions to initiate the formation of encounter complexes, (2) partial attachment of TAD2, and finally (3) full attachment of TAD2 to the correct binding pocket of Taz2. Furthermore, machine-learning-based PathDetect-SOM was used to identify two binding pathways, the encounter complexes, and the intermediate states.

Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein.

Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein

Interaction Between P53 N Terminus and Core Domain Regulates Specific and Nonspecific DNA Binding.

The MDM2-binding Region in the Transactivation Domain of P53 Also Acts As a Bcl-X(L)-binding Motif.

Intrinsically Disordered N-terminal Domain (NTD) of P53 Interacts with Mitochondrial PTP Regulator Cyclophilin D

Activation of p53: how phosphorylated Ser15 triggers sequential phosphorylation of p53 at Thr18 by CK1δ

Solution structure of MUL1-RING domain and its interaction with p53 transactivation domain

Anchoring Intrinsically Disordered Proteins To Multiple Targets: Lessons From N-Terminus Of The P53 Protein

Modulation of the p53-MDM2 Interaction by Phosphorylation of Thr18: A Computational Study

A Conserved Mechanism for Binding of p53 DNA-Binding Domain and Anti-Apoptotic Bcl-2 Family Proteins

Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation

Mdm-2 binding and TAFII31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and Asp21

P300/mdm2 Complexes Participate in MDM2-mediated P53 Degradation.

Global Conformational Selection and Local Induced Fit for the Recognition Between Intrinsic Disordered P53 and CBP.

Structure Of P53 Binding To The Bax Response Element Reveals Dna Unwinding And Compression To Accommodate Base-Pair Insertion

The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription

Deciphering the Mystery in p300 Taz2-p53 TAD2 Recognition

p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60.

Structure of Human Mdm2 Complexed with Rpl11 Reveals the Molecular Basis of P53 Activation

Binding of p53 to the KIX Domain of CREB Binding Protein

NMR Studies of the Interaction Between Human Programmed Cell Death 5 and Human P53.